FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38591311000001103: Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1377191000001119 Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1377201000001117 Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Is a Arsenic 12mg/6ml solution for infusion vials true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Is a Trisenox true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient Arsenic trioxide true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) 10 vial Has AMP True Trisenox 12mg/6ml concentrate for solution for infusion vials (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start